| dbo:abstract
|
- Cerebrovascular diseases in Australia are a major health issue. Cerebrovascular disease is a significant challenge to Australia due to it being a prominent cause of death in Australians and the difficulties it poses for carers and the health system in addition to individuals with cerebrovascular disease. Stroke is the deadliest cerebrovascular disease in Australia accounting for 84.24% of all deaths caused by cerebrovascular diseases. The death rate of cerebrovascular diseases is decreasing, with cerebrovascular disease in 2008-2018 falling from the third to fourth leading cause of death for men and second to third leading cause of death for women during this time period. In 2015, stroke was the tenth leading cause of burden of disease, accounting for 2.7% of the overall burden. This cause of disease burden has decreased from 2003-2015 with stroke falling from the second leading cause of disease burden to the tenth during this time period. Aboriginal and Torres Strait Islander people and people from low-socioeconomic areas experience higher rates of prevalence and mortality from stroke than non-Indigenous Australians. Cerebrovascular diseases have significant economic impacts and social impacts on survivors and the Australian economy. In 2012, the cost of lost earnings due to decreased employment of working age stroke survivors was A$975 million and the cost of absenteeism for working stroke survivors was $1,138 billion. In the 2011 survey of Australian stroke survivors and their carers, stroke survivors with a partner or spouse experienced a deterioration of their relationship in 57% of cases, and 47% of stroke survivors’ carers who engaged in leisure activities experienced a moderate to severe reduction in their ability to partake in these activities after becoming a carer. Due to the challenges cerebrovascular diseases pose to Australia, the Australian Government has allocated significant health expenditure to these diseases. The Medical Research Future Fund and National Health and Medical Research Council are two government-owned research bodies that have committed $220 million over 10 years into the Cardiovascular Health Mission, which includes the aim to reduce the prevalence of cardiovascular diseases, including stroke, in Australia. The University of Melbourne and Royal Melbourne Hospital received $1 million from these two research bodies to develop more effective early stroke diagnosis tools for air and road ambulances. (en)
|
| dbo:thumbnail
| |
| dbo:wikiPageExternalLink
| |
| dbo:wikiPageID
| |
| dbo:wikiPageLength
|
- 20322 (xsd:nonNegativeInteger)
|
| dbo:wikiPageRevisionID
| |
| dbo:wikiPageWikiLink
| |
| dbp:wikiPageUsesTemplate
| |
| dcterms:subject
| |
| rdfs:comment
|
- Cerebrovascular diseases in Australia are a major health issue. Cerebrovascular disease is a significant challenge to Australia due to it being a prominent cause of death in Australians and the difficulties it poses for carers and the health system in addition to individuals with cerebrovascular disease. Stroke is the deadliest cerebrovascular disease in Australia accounting for 84.24% of all deaths caused by cerebrovascular diseases. The death rate of cerebrovascular diseases is decreasing, with cerebrovascular disease in 2008-2018 falling from the third to fourth leading cause of death for men and second to third leading cause of death for women during this time period. In 2015, stroke was the tenth leading cause of burden of disease, accounting for 2.7% of the overall burden. This cause (en)
|
| rdfs:label
|
- Cerebrovascular diseases in Australia (en)
|
| owl:sameAs
| |
| prov:wasDerivedFrom
| |
| foaf:depiction
| |
| foaf:isPrimaryTopicOf
| |
| is dbo:wikiPageRedirects
of | |
| is dbo:wikiPageWikiLink
of | |
| is foaf:primaryTopic
of | |
